Agios Pharmaceuticals (AGIO) FCF Margin Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) FCF Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 112,716.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112,716.00 |
| Dec 31, 2025 | 94,655.00 |
| Sep 30, 2025 | 149,035.00 |
| Jun 30, 2025 | 65,351.00 |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2023 | -105,823.00 |
| Sep 30, 2023 | -50,161.00 |
| Jun 30, 2023 | -91,093.00 |
| Mar 31, 2023 | -157,687.00 |
| Dec 31, 2022 | -116,451.00 |
| Sep 30, 2022 | -182,790.00 |
| Jun 30, 2022 | -93,872.00 |
| Mar 31, 2022 | -1.17 Mn |
| Dec 31, 2020 | 75,981.00 |
| Sep 30, 2020 | 36,990.00 |
| Dec 31, 2019 | 412.00 |
| Sep 30, 2019 | 19,937.00 |
| Jun 30, 2019 | -259,198.00 |
| Mar 31, 2019 | -28,568.00 |
| Dec 31, 2018 | -5,559.00 |